ORGANOGENESIS HOLDINGS INC. Deferred Tax Assets, Other Loss Carryforwards
ORGANOGENESIS HOLDINGS INC. (ORGO) had Deferred Tax Assets, Other Loss Carryforwards of $13.85 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOtherLossCarryforwards · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Other Loss Carryforwards $13.85M.
- 2024-12-31: Deferred Tax Assets, Other Loss Carryforwards $7.11M.
- 2023-12-31: Deferred Tax Assets, Other Loss Carryforwards $6.40M.
- 2022-12-31: Deferred Tax Assets, Other Loss Carryforwards $5.66M.
| Period end | Deferred Tax Assets, Other Loss Carryforwards | Deferred Tax Assets, Other Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $13.85M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $7.11M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $6.40M 10-K · filed 2025-02-27 | |
| 2022-12-31 | $5.66M 10-K · filed 2024-02-29 | |
| 2021-12-31 | $7.56M 10-K · filed 2023-03-01 | |
| 2020-12-31 | $5.83M 10-K · filed 2022-03-01 | |
| 2019-12-31 | $4.83M 10-K · filed 2021-03-16 | $11.86M 10-K · filed 2020-03-09 |
| 2018-12-31 | $12.22M 10-K · filed 2020-03-09 | |
| 2017-12-31 | $8.71M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |